TABLE 1.
Baseline characteristics stratified by presence of hepatic steatosis on CT scan after a mean 6.3 years of follow-up
| Characteristics | No hepatic steatosis at follow-up (n = 568) | Hepatic steatosis at follow-up (n = 117) |
|---|---|---|
| Age (y) | 44.9 (6.1) | 45.9 (7.0) |
| Women n, (%) | 283 (49.8%) | 38 (32.5%) |
| Smoking n, (%) | 45 (7.9%) | 18 (15.4%) |
| Alcohol (drinks/wk) | 3 (3.2) | 2 (3.2) |
| Diabetes n, (%) | 9 (1.6%) | 2 (1.7%) |
| Impaired fasting glucose n, (%) | 105 (18.8%) | 43 (37.4%) |
| Fasting Glucose (mg/dL) | 95 (18) | 98 (12) |
| Metabolic Syndrome n, (%) | 82 (14.4%) | 47 (40.2%) |
| Systolic blood pressure (mm Hg) | 116 (13) | 121 (13) |
| Diastolic Blood Pressure (mm Hg) | 75(9) | 79(8) |
| Hypertension n, (%) | 74 (13.0%) | 33 (28.2%) |
| Pulse pressure (mm Hg) | 41(9) | 43 (10) |
| Lipid lowering therapy n, (%) | 46 (8.1%) | 19 (16.2%) |
| Total Cholesterol (mg/dL) | 190 (34) | 198 (32) |
| HDL Cholesterol (mg/dL) | 55 (16) | 47 (13) |
| Low HDL Cholesterol n, (%) | 136 (23.9%) | 47 (40.2%) |
| Triglycerides (mg/dL) | 100 (53) | 144 (93) |
| High Triglycerides n, (%) | 120 (21.1%) | 53 (45.3%) |
| LDL Cholesterol (mg/dL) | 115 (31) | 123 (27) |
| Alanine aminotransferase (IU/L) | 24 (14) | 30 (15) |
| Aspartate aminotransferase (IU/L) | 23(8) | 25 (10) |
| BMI (kg/m2) | 25.9 (4.4) | 29.9 (4.8) |
| BMI Category n, (%) | ||
| Normal weight (BMI < 25 kg/m2) | 277 (48.8%) | 13 (11.1%) |
| Overweight (25 < BMI < 30 kg/m2) | 210 (37.0%) | 54 (46.2%) |
| Obese (BMI > 30 kg/m2) | 81 (14.3%) | 50 (42.7%) |
| Visceral adipose tissue (cm3) | 1273 (712) | 2038 (790) |
| Subcutaneous adipose tissue (cm3) | 2444 (1264) | 3368 (1501) |
| Waist circumference (cm) | 91.1 (12.3) | 103.1 (12.9) |
| Liver phantom ratio | 0.38 (0.02) | 0.36 (0.02) |
| Uric acid (mg/dL) | 5.1 (1.3) | 5.9 (1.4) |
BMI, body mass index; HDL, high-density lipoprotein
Continuous variables expressed as mean (SD), categorical variables as n, (%)